Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 1st GBHI-Conference – Conference Report now available 3rd GBHI conference – program is online Who is a healthy subject? German Pharm-Tox Summit 2017 in Heidelberg 2nd part of Introductory Course in Exploratory Medicines Development scheduled for February 2017 Introductory Course in Exploratory Medicines Development – taking place in our offices in Oberursel! Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Hypothalamic EMA Allergy Dose linearity HTA Life cycle management Standardisation Pilot study MDI SAS Immunogenicity Healthy subjects Endpoint Sequential designs Efficacy Cardiovascular surveillance Authorities Recruitment rates Consultancy Steady state IB Ovulation inhibition Post authorisation Sensitisation trials Experience Oncologic network CDASH MCID Oncological patients Scientific expertise FDA DPI IVIVC Female adolescents Lung Phase IV Monitoring Local tolerability Non interventional Statistical programming Phase IIa trials Uveitis Scientific advice Postmenopausal women Data management Dry powder inhaler Clinical development program Metered dose inhaler IMPD Patch adhesion Investigators brochure Data Validation Plan Ophthalmology Phase I First in human Highly variable drugs SocraTec C&S Phase III Slit lamp microscopy Xerostomia Elpro Contraception NIS Intensive assessment station Axis DUS CDM Spacious archive Bioavailability Project Management Network TTS ADAM Clinical study Legal Information In vitro in vivo correlation Good Clinical Practice Quality Management System Hormone replacement therapy Macular Pharmacokinetics US CFR 21 Part 11 Centralised procedure Quality Copyright WinNonlin Feasibility OTC CRF Edema Source Data Verification Absorption COPD Pharmacokintetics HRT Adrenocortical Eye disease Safety Children Statistical services CDISC Oncology Protocol US FDA Audit Pharmacology Biosimilars CDSIC Biopharmaceutical Patient recruitment IEC HPA axis Subcontractor qualification Pituitary Informed Consent Procedure ANVISA PAES Bioequivalence Patients Sore throat Competence Early phase Biometrics Data Management Plan Clinical Monitoring Product development Referral system PASS Ocular tolerability MMM SDV ICF Database Anaesthesiologist DDI Thuringia Creativity Protocol development Dry eye Drug Food Interaction Inhalatives Dermal irritation Phase I Unit Transdermal therapeutic system Asthma Training Biopharmaceutics Phase II Patch Expert DFI Phase IIb trials Rhine Main area Degeneration Inspection CRA Sample size estimation Pragmatism Ophthalmological trials Clinical trials GLP Clinical pharmacology unit Statistical Analysis Plan Standard operating procedure Paediatricians GCP training Glaucoma Quality Assurance Cough Auditing Gynaecological trials Central surveillance system Design development CRO FIM Charcoal Pulse oximetry plethysmography Ophthalmologist Legal representative SOP based Common cold AGAH Drug Drug Interaction Absorption windows GCP Pharmacodynamic studies  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page